Rigel Pharmaceuticals, Inc.
RIGL
$26.55
$0.602.31%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 860.81% | -53.20% | 420.82% | -20.19% | 15.46% |
| Total Depreciation and Amortization | -0.33% | -0.66% | 0.50% | 0.00% | -1.15% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -8,502.87% | 107.84% | -1,279.16% | 78.58% | -31.23% |
| Change in Net Operating Assets | 54.68% | -201.32% | 145.23% | -631.77% | -136.05% |
| Cash from Operations | -8.53% | -21.31% | 3,519.60% | -106.16% | -33.10% |
| Capital Expenditure | 200.00% | -- | -- | -- | -160.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | 176.92% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 23.49% | -42.48% | -120.58% | 3.72% | -389.49% |
| Cash from Investing | 23.55% | -42.53% | -120.58% | 3.32% | -387.06% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -31.44% | 921.77% | -13.64% | -66.96% | 827.22% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 100.00% |
| Cash from Financing | -207.05% | 921.77% | -13.64% | -66.96% | 114.89% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -63.23% | -163.46% | 170.06% | -316.88% | -67.68% |